News
-
-
COMMUNIQUÉ DE PRESSE
aap Implantate AG closes the first half of the year with sales of € 6.2 million; clinical trial nears positive conclusion
aap Implantate AG reports €6.2 million sales in the first half of 2025, with clinical trial near positive conclusion. Regional growth in EMEA, strong performance in APAC, US tariff impact mitigated -
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
aap Implantate AG: Full admission of all previously unadmitted shares, introduction to stock exchange trading and termination of lock-up agreements
aap Implantate AG announces full admission of previously unadmitted shares to the Frankfurt Stock Exchange's regulated market, along with the termination of lock-up agreements -
-
